(SHO) Sunstone Hotel Investors - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8678921011
Stock: Hotels, Resorts, Rooms, REIT
Total Rating 24
Risk 58
Buy Signal -0.38
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.97% |
| Yield on Cost 5y | 3.58% |
| Yield CAGR 5y | 53.26% |
| Payout Consistency | 60.3% |
| Payout Ratio | 8.7% |
| Risk 5d forecast | |
|---|---|
| Volatility | 26.0% |
| Relative Tail Risk | -7.41% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.50 |
| Alpha | -29.25 |
| Character TTM | |
|---|---|
| Beta | 1.064 |
| Beta Downside | 1.117 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.56% |
| CAGR/Max DD | -0.04 |
Description: SHO Sunstone Hotel Investors January 15, 2026
Sunstone Hotel Investors, Inc. (NYSE: SHO) is a lodging REIT that, as of the latest filing, owns 14 hotels totaling 6,999 rooms, the majority of which operate under nationally recognized brands. The company’s stated strategy focuses on creating long-term stakeholder value by acquiring, actively managing, and eventually disposing of well-located hotel and resort assets.
Key industry metrics that shape SHO’s outlook include a U.S. hotel occupancy rate of roughly 70% in Q4 2023 and a RevPAR increase of about 5% year-over-year, driven largely by robust leisure travel demand and modest ADR growth. The REIT is also sensitive to macro-economic factors such as the Fed’s interest-rate policy, which influences both financing costs and discretionary consumer spending. Additionally, Sunstone’s pipeline includes two planned acquisitions slated for 2025, potentially adding ~1,200 rooms and diversifying its geographic exposure.
For a deeper, data-driven valuation of SHO, the ValueRay platform offers a transparent, model-backed analysis worth reviewing.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 18.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.25 > 1.0 |
| NWC/Revenue: 15.50% < 20% (prev -58.42%; Δ 73.92% < -1%) |
| CFO/TA 0.06 > 3% & CFO 175.6m > Net Income 18.2m |
| Net Debt (804.9m) to EBITDA (198.6m): 4.05 < 3 |
| Current Ratio: 2.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (190.1m) vs 12m ago -5.61% < -2% |
| Gross Margin: 46.43% > 18% (prev 0.55%; Δ 4588 % > 0.5%) |
| Asset Turnover: 30.42% > 50% (prev 29.21%; Δ 1.21% > 0%) |
| Interest Coverage Ratio: 1.39 > 6 (EBITDA TTM 198.6m / Interest Expense TTM 47.1m) |
Altman Z'' -0.81
| A: 0.05 (Total Current Assets 252.3m - Total Current Liabilities 106.9m) / Total Assets 3.05b |
| B: -0.20 (Retained Earnings -621.6m / Total Assets 3.05b) |
| C: 0.02 (EBIT TTM 65.6m / Avg Total Assets 3.08b) |
| D: -0.57 (Book Value of Equity -619.7m / Total Liabilities 1.09b) |
| Altman-Z'' Score: -0.81 = CCC |
Beneish M -3.04
| DSRI: 0.84 (Receivables 29.4m/34.1m, Revenue 937.9m/910.3m) |
| GMI: 1.19 (GM 46.43% / 55.13%) |
| AQI: 0.96 (AQ_t 0.91 / AQ_t-1 0.95) |
| SGI: 1.03 (Revenue 937.9m / 910.3m) |
| TATA: -0.05 (NI 18.2m - CFO 175.6m) / TA 3.05b) |
| Beneish M-Score: -3.04 (Cap -4..+1) = AA |
What is the price of SHO shares?
As of February 07, 2026, the stock is trading at USD 9.15 with a total of 1,339,555 shares traded.
Over the past week, the price has changed by +4.33%, over one month by -3.07%, over three months by -0.42% and over the past year by -15.12%.
Over the past week, the price has changed by +4.33%, over one month by -3.07%, over three months by -0.42% and over the past year by -15.12%.
Is SHO a buy, sell or hold?
Sunstone Hotel Investors has received a consensus analysts rating of 3.80.
Therefor, it is recommend to hold SHO.
- StrongBuy: 4
- Buy: 0
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SHO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 10 | 9.3% |
| Analysts Target Price | 10 | 9.3% |
| ValueRay Target Price | 9.6 | 5.2% |
SHO Fundamental Data Overview February 03, 2026
P/E Trailing = 438.5
P/E Forward = 181.8182
P/S = 1.7757
P/B = 1.0138
P/EG = 1.21
Revenue TTM = 937.9m USD
EBIT TTM = 65.6m USD
EBITDA TTM = 198.6m USD
Long Term Debt = 917.5m USD (from longTermDebt, last quarter)
Short Term Debt = 8.57m USD (from shortTermDebt, last quarter)
Debt = 926.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 804.9m USD (from netDebt column, last quarter)
Enterprise Value = 2.47b USD (1.67b + Debt 926.0m - CCE 121.1m)
Interest Coverage Ratio = 1.39 (Ebit TTM 65.6m / Interest Expense TTM 47.1m)
EV/FCF = 15.64x (Enterprise Value 2.47b / FCF TTM 158.0m)
FCF Yield = 6.39% (FCF TTM 158.0m / Enterprise Value 2.47b)
FCF Margin = 16.84% (FCF TTM 158.0m / Revenue TTM 937.9m)
Net Margin = 1.94% (Net Income TTM 18.2m / Revenue TTM 937.9m)
Gross Margin = 46.43% ((Revenue TTM 937.9m - Cost of Revenue TTM 502.4m) / Revenue TTM)
Gross Margin QoQ = 44.03% (prev 50.25%)
Tobins Q-Ratio = 0.81 (Enterprise Value 2.47b / Total Assets 3.05b)
Interest Expense / Debt = 1.40% (Interest Expense 12.9m / Debt 926.0m)
Taxrate = 9.39% (137.0k / 1.46m)
NOPAT = 59.4m (EBIT 65.6m * (1 - 9.39%))
Current Ratio = 2.36 (Total Current Assets 252.3m / Total Current Liabilities 106.9m)
Debt / Equity = 0.47 (Debt 926.0m / totalStockholderEquity, last quarter 1.96b)
Debt / EBITDA = 4.05 (Net Debt 804.9m / EBITDA 198.6m)
Debt / FCF = 5.10 (Net Debt 804.9m / FCF TTM 158.0m)
Total Stockholder Equity = 2.03b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.59% (Net Income 18.2m / Total Assets 3.05b)
RoE = 0.90% (Net Income TTM 18.2m / Total Stockholder Equity 2.03b)
RoCE = 2.22% (EBIT 65.6m / Capital Employed (Equity 2.03b + L.T.Debt 917.5m))
RoIC = 2.27% (NOPAT 59.4m / Invested Capital 2.62b)
WACC = 6.77% (E(1.67b)/V(2.59b) * Re(9.83%) + D(926.0m)/V(2.59b) * Rd(1.40%) * (1-Tc(0.09)))
Discount Rate = 9.83% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.42%
[DCF Debug] Terminal Value 82.01% ; FCFF base≈162.5m ; Y1≈152.6m ; Y5≈142.4m
Fair Price DCF = 13.28 (EV 3.33b - Net Debt 804.9m = Equity 2.52b / Shares 189.9m; r=6.77% [WACC]; 5y FCF grow -7.83% → 2.90% )
EPS Correlation: -28.70 | EPS CAGR: -25.13% | SUE: 0.06 | # QB: 0
Revenue Correlation: 34.88 | Revenue CAGR: 7.66% | SUE: 0.48 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.01 | Chg30d=+0.020 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=0.13 | Chg30d=-0.010 | Revisions Net=-1 | Growth EPS=+0.0% | Growth Revenue=+3.6%
P/E Forward = 181.8182
P/S = 1.7757
P/B = 1.0138
P/EG = 1.21
Revenue TTM = 937.9m USD
EBIT TTM = 65.6m USD
EBITDA TTM = 198.6m USD
Long Term Debt = 917.5m USD (from longTermDebt, last quarter)
Short Term Debt = 8.57m USD (from shortTermDebt, last quarter)
Debt = 926.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 804.9m USD (from netDebt column, last quarter)
Enterprise Value = 2.47b USD (1.67b + Debt 926.0m - CCE 121.1m)
Interest Coverage Ratio = 1.39 (Ebit TTM 65.6m / Interest Expense TTM 47.1m)
EV/FCF = 15.64x (Enterprise Value 2.47b / FCF TTM 158.0m)
FCF Yield = 6.39% (FCF TTM 158.0m / Enterprise Value 2.47b)
FCF Margin = 16.84% (FCF TTM 158.0m / Revenue TTM 937.9m)
Net Margin = 1.94% (Net Income TTM 18.2m / Revenue TTM 937.9m)
Gross Margin = 46.43% ((Revenue TTM 937.9m - Cost of Revenue TTM 502.4m) / Revenue TTM)
Gross Margin QoQ = 44.03% (prev 50.25%)
Tobins Q-Ratio = 0.81 (Enterprise Value 2.47b / Total Assets 3.05b)
Interest Expense / Debt = 1.40% (Interest Expense 12.9m / Debt 926.0m)
Taxrate = 9.39% (137.0k / 1.46m)
NOPAT = 59.4m (EBIT 65.6m * (1 - 9.39%))
Current Ratio = 2.36 (Total Current Assets 252.3m / Total Current Liabilities 106.9m)
Debt / Equity = 0.47 (Debt 926.0m / totalStockholderEquity, last quarter 1.96b)
Debt / EBITDA = 4.05 (Net Debt 804.9m / EBITDA 198.6m)
Debt / FCF = 5.10 (Net Debt 804.9m / FCF TTM 158.0m)
Total Stockholder Equity = 2.03b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.59% (Net Income 18.2m / Total Assets 3.05b)
RoE = 0.90% (Net Income TTM 18.2m / Total Stockholder Equity 2.03b)
RoCE = 2.22% (EBIT 65.6m / Capital Employed (Equity 2.03b + L.T.Debt 917.5m))
RoIC = 2.27% (NOPAT 59.4m / Invested Capital 2.62b)
WACC = 6.77% (E(1.67b)/V(2.59b) * Re(9.83%) + D(926.0m)/V(2.59b) * Rd(1.40%) * (1-Tc(0.09)))
Discount Rate = 9.83% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.42%
[DCF Debug] Terminal Value 82.01% ; FCFF base≈162.5m ; Y1≈152.6m ; Y5≈142.4m
Fair Price DCF = 13.28 (EV 3.33b - Net Debt 804.9m = Equity 2.52b / Shares 189.9m; r=6.77% [WACC]; 5y FCF grow -7.83% → 2.90% )
EPS Correlation: -28.70 | EPS CAGR: -25.13% | SUE: 0.06 | # QB: 0
Revenue Correlation: 34.88 | Revenue CAGR: 7.66% | SUE: 0.48 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.01 | Chg30d=+0.020 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=0.13 | Chg30d=-0.010 | Revisions Net=-1 | Growth EPS=+0.0% | Growth Revenue=+3.6%